Scribe Biosciences: Funding, Investors & Team (Oct 2026)
Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs.
Scribe Biosciences has raised $500k across 2 funding rounds on record, the most recent an undisclosed round announced in Jun 2023.
Scribe Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Scribe Biosciences Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Scribe Biosciences raised $500k in an undisclosed round announced in May 2021.
2.1 years later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
Scribe Biosciences Founders and Leadership Team
Contact details for the Scribe Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Scribe Biosciences Funding Compared to Other Biotechnology Startups
Funded Startups Like Scribe Biosciences in Biotechnology and San Francisco
Companies Similar to Scribe Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Scribe Biosciences Funding FAQs
What does Scribe Biosciences do?
Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs.
How much funding has Scribe Biosciences raised?
Scribe Biosciences has raised $500k across 2 rounds on record.
When did Scribe Biosciences last raise funding?
Scribe Biosciences' most recent funding round on record was announced in Jun 2023. The amount was not disclosed.
Who founded Scribe Biosciences?
FundedIQ lists Russell Cole (Founder) at Scribe Biosciences.
Where is Scribe Biosciences headquartered?
Scribe Biosciences is based in San Francisco, California, United States.
How many employees does Scribe Biosciences have?
Scribe Biosciences is in the 1-10 employee band.
About FundedIQ's Scribe Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scribe Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.